A randomized clinical trial: timing of indwelling urethral catheter removal following transurethral resection of prostate.
Saddam Al DemourMohammad T Al-ZubiMera A AbabnehSamer F Al-RawashdahMuayyad AhmadPublished in: Future science OA (2024)
Aim: We aimed to evaluate early versus delayed removal of the indwelling urethral catheter (IUC) following transurethral resection of prostate (TURP). Methods: In this clinical trial conducted between July 2016 and June 2020, 90 patients underwent TURP were randomized equally into: group A, early IUC removal (24 h), and group B, delayed IUC removal (72 h). Results: The mean length of hospital stay was longer among the patients in group B. There were no significant differences in recatheterization, secondary bleeding, or UTI between groups A and B. The mean VAS score and CRBD were higher in group B. Conclusion: Early IUC removal following TURP is safe approach with favorable clinical outcomes. Clinical Trial Registration: NCT04363970 (clinicaltrials.gov).
Keyphrases
- clinical trial
- end stage renal disease
- prostate cancer
- ejection fraction
- chronic kidney disease
- benign prostatic hyperplasia
- newly diagnosed
- double blind
- open label
- prognostic factors
- randomized controlled trial
- urinary tract infection
- atrial fibrillation
- study protocol
- placebo controlled
- muscle invasive bladder cancer
- acute care